tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
NEUP
Neuphoria Therapeutics
RESEARCH TOOLSreports
Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Financial Statements

301 Followers

Neuphoria Therapeutics Financial Overview

Neuphoria Therapeutics's market cap is currently $18.27M. The company's EPS TTM is $; its P/E ratio is -0.31; Neuphoria Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total Revenue$ 15.65M$ 0.00$ 0.00$ 383.16K$ 0.00
Gross Profit$ 15.65M$ -662.99K$ -671.48K$ 383.16K$ 0.00
Operating Income$ -1.13M$ -26.79M$ -33.09M$ -31.02M$ -8.96M
EBITDA$ -121.90K$ -25.65M$ -31.45M$ -30.25M$ -4.51M
Net Income$ -369.63K$ -23.19M$ -32.18M$ -31.62M$ -6.53M
Balance Sheet
Cash & Short-Term Investments$ 21.59M$ 12.61M$ 8.06M$ 33.56M$ 21.41M
Total Assets$ 43.44M$ 27.65M$ 19.39M$ 65.30M$ 40.77M
Total Debt$ 226.49K$ 272.74K$ 257.55K$ 693.55K$ 652.04K
Net Debt$ -21.37M$ -12.34M$ -7.80M$ -32.87M$ -20.76M
Total Liabilities$ 14.57M$ 10.16M$ 4.74M$ 8.40M$ 5.01M
Stockholders' Equity$ 28.87M$ 17.49M$ 14.65M$ 56.91M$ 35.76M
Cash Flow
Free Cash Flow$ 77.23M$ -14.68M$ -9.85M$ -21.75M$ -5.67M
Operating Cash Flow$ 77.23M$ -14.68M$ -9.85M$ -21.75M$ -5.66M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 621.64K$ -60.26K
Financing Cash Flow$ 1.53B$ 15.11M$ 2.60M$ 26.99M$ 23.71M
Currency in USD

Neuphoria Therapeutics Earnings and Revenue History

Income Statement >

Neuphoria Therapeutics Debt to Assets

Balance Sheet >

Neuphoria Therapeutics Cash Flow

Cash Flow >

Neuphoria Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >